ESC Premium Access

A novel three-dimensional visualization system revealed an essential adaptive angiogenic response during the early phase of pulmonary hypertension

Topic: Hypertension, Pulmonary Hypertension

Congress Presentation

About the speaker

Doctor Takayuki Fujiwara

University of Tokyo Hospital, Tokyo (Japan)
0 follower

6 more presentations in this session

Hyperuricemia impaired nitric oxide bioavailablity and deteriorated pulmonary arterial hypertension via a uric acid transporter, URATv1 in xanthine oxidoreductase (XOR)-independent manner

Speaker: Doctor T. Watanabe (Fukuoka, JP)


Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction

Speaker: Professor V. Schini-Kerth (Strasbourg, FR)


Pulmonary hypertension: reduction of vascular and cardiac remodeling by a new inhibitor of p38-alpha MAPK

Speaker: Miss G. Silva (Rio de Janeiro, BR)


Selective inhibition of Histone deacetylases reverses vascular remodelling and improves right ventricle function in pulmonary hypertension

Speaker: Doctor K. Kurakula (Amsterdam, NL)


Beta3-adrenergic stimulation restores endothelial mitochondrial dynamics and prevents pulmonary arterial hypertension

Speaker: Doctor E. Oliver (Madrid, ES)


Access the full session

Pulmonary Hypertension: Targets for Therapies

Speakers: Doctor T. Fujiwara, Doctor T. Watanabe, Professor V. Schini-Kerth, Miss G. Silva, Doctor K. Kurakula...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb